Citation Impact
Citing Papers
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Iduronic Acid-Containing Glycosaminoglycans on Target Cells Are Required for Efficient Respiratory Syncytial Virus Infection
2000
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
2006
Functional Implication of Secretory Proteases Derived from Microglia in the Central Nervous System.
1996
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.
1992
Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
2009
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Effects of SanOrg123781A, a Synthetic Hexadecasaccharide, in a Mouse Model of Electrically Induced Carotid Artery Injury: Synergism with the Antiplatelet Agent Clopidogrel
2004
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
INHIBITION OF ADP‐INDUCED PLATELET AGGREGATION BY CLOPIDOGREL IS RELATED TOCYP2C19GENETIC POLYMORPHISMS
2008
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Calibrated Automated Thrombin Generation Measurement in Clotting Plasma
2003 Standout
Usefulness of High Clopidogrel Maintenance Dose According to CYP2C19 Genotypes in Clopidogrel Low Responders Undergoing Coronary Stenting for Non ST Elevation Acute Coronary Syndrome
2011
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
2009
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
New Antithrombotic Drugs
2012
Protective immune mechanisms in helminth infection
2007 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
1998 StandoutNatureNobel
Human umbilical vein endothelial cells express high affinity receptors for factor Xa
1997
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Interleukin-4 and lnterleukin-13: Their Similarities and Discrepancies
1998
Involvement of u‐PA in the anti‐apoptotic activity of TGFβ for vascular smooth muscle cells
1997
The Primary Binding Subunit of the Human Interleukin-4 Receptor Is Also a Component of the Interleukin-13 Receptor
1995
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
2000 StandoutNobel
Thrombin signalling and protease-activated receptors
2000 StandoutNature
Antithrombotic Therapy for VTE Disease
2012 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
2013 Standout
Structure and Stereochemistry of the Active Metabolite of Clopidogrel
2002
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Cell biology of tissue factor, the principal initiator of blood coagulation
1996
Adjunctive Therapy for Septic Shock: A Review of Experimental Approaches
1995
Production of chemotactic peptides by neutrophil degradation of heparin cofactor II
1990
Expression of Janus Kinase 3 in Human Endothelial and Other Non-lymphoid and Non-myeloid Cells
1996
Interleukin‐13 and interleukin‐13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis
2001
An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.
1995
In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis
2011 StandoutNobel
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
CYP2C19*2 and prognosis after an acute coronary syndrome: Insights from a Portuguese center
2012
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome
2008
Effects of Aspirin and Clopidogrel versus Oral Anticoagulation on Platelet Function and on Coagulation in Patients with Nonvalvular Atrial Fibrillation (CLAFIB)
2002
Disseminated Intravascular Coagulation
1999 Standout
Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP‐ and thrombin‐induced human platelet activation
2004 StandoutNobel
Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist
2003
Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine
2004
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis
2003
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
2005 Standout
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
Tolerability and Clinical Efficacy of Desmin in the Treatment of Superficial Thrombovaricophlebitis
1996
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets
2011 StandoutNobel
Maturation of the hemostatic system during childhood
1992 Standout
Platelet Activation and Blood Coagulation
2002
Serpin Structure, Mechanism, and Function
2002 Standout
Hypercoagulability and thrombosis
1994
Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality
1999 Standout
Identification and Biological Activity of the Active Metabolite of Clopidogrel
2000
Evaluation of a CYP2C19 genotype panel on the GenMark eSensor® platform and the comparison to the Autogenomics Infiniti™ and Luminex CYP2C19 panels
2011
JAKS AND STATS: Biological Implications
1998 Standout
Antibody to Thrombin Receptor Inhibits Neointimal Smooth Muscle Cell Accumulation Without Causing Inhibition of Platelet Aggregation or Altering Hemostatic Parameters After Angioplasty in Rat
1998
The Basic and Clinical Pharmacology of Nonpeptide Vasopressin Receptor Antagonists
2001
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
Altered Vascular Injury Responses in Mice Deficient in Protease-Activated Receptor-1
1999
Leukocyte chemoattractant peptides from the serpin heparin cofactor II.
1991
Plasminogen Activator Expression in Rat Arterial Smooth Muscle Cells Depends on Their Phenotype and Is Modulated by Cytokines
1998
Impact of CYP2C19 Polymorphisms on the Antiplatelet Effect of Clopidogrel in an Actual Clinical Setting in Japan
2009
Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins
1993
Alternative Activation of Macrophages: An Immunologic Functional Perspective
2008 Standout
Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor
2005 StandoutNobel
Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
2000
Contrasting Effects of Plasminogen Activators, Urokinase Receptor, and LDL Receptor–Related Protein on Smooth Muscle Cell Migration and Invasion
1996
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Minimizing the Risks of Anticoagulants and Platelet Inhibitors
2010
Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis
1998
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1
1998 Standout
Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
2007
Low-Molecular-Weight Heparins
1997 Standout
The Metabolic Syndrome
2008 Standout
Interleukin-13: Central Mediator of Allergic Asthma
1998 StandoutScience
Activation of Platelet Function Through G Protein–Coupled Receptors
2006
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Regulation of endothelial and mesothelial cell function by interleukin- 13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production
1994
Physiology of Microglia
2011 Standout
Works of F. Dol being referenced
Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel
1992
IL‐4 and IL‐13 exhibit comparable abilities to reduce pyrogen‐induced expression of procoagulant activity in endothelial cells and monocytes
1993
Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.
1998
Inactivation of heparin cofactor II by polymorphonuclear leukocytes
1987
Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide
1997
Neutralization of dermatan sulfate and by protamine sulfate and polybrene
1989
Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor Effect of heparin
1992
Potentiating Effect of Clopidogrel and SR 46349, a Novel 5-HT2 Antagonist, on Streptokinase-Induced Thrombolysis in the Rabbit
1993
Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells
1995
The Consumption of Antithrombin III During Coagulation, Its Consequences for the Calculation of Prothrombinase Activity and the Standardisation of Heparin Activity
1992
A Simple Method to Measure Dermatan Sulfate at Sub-Microgram Concentrations in Plasma
1988
DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
1996
Further Studies on the Mechanisms for the Antithrombotic Effects of Sulfated Polysaccharides in Rabbits
1988
ADP-dependence of platelet activation induced by a thrombin receptor agonist.
1993
Effect of Clopidogrel on Thrombin Generation in Platelet-Rich Plasma in the Rat
1999
Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells.
1994
Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans
1989